Molecular findings in maxillofacial bone tumours and its diagnostic value

A.H.G. Cleven, W.H. Schreuder, E. Groen, H.M. Kroon, D. Baumhoer

Research output: Contribution to journalReview articleAcademicpeer-review

16 Citations (Scopus)

Abstract

According to the WHO, mesenchymal tumours of the maxillofacial bones are subdivided in benign and malignant maxillofacial bone and cartilage tumours, fibro-osseous and osteochondromatous lesions as well as giant cell lesions and bone cysts. The histology always needs to be evaluated considering also the clinical and radiological context which remains an important cornerstone in the classification of these lesions. Nevertheless, the diagnosis of maxillofacial bone tumours is often challenging for radiologists as well as pathologists, while an accurate diagnosis is essential for adequate clinical decision-making. The integration of new molecular markers in a multidisciplinary diagnostic approach may not only increase the diagnostic accuracy but potentially also identify new druggable targets for precision medicine. The current review provides an overview of the clinicopathological and molecular findings in maxillofacial bone tumours and discusses the diagnostic value of these genetic aberrations.

Original languageEnglish
Pages (from-to)159-174
Number of pages16
JournalVirchows Archiv
Volume476
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • Fibro-osseous lesions
  • Genetic aberrations
  • Maxillofacial bone tumours
  • Multidisciplinary diagnostic approach

Cite this